## Abstract Despite earlier detection and recent advances in surgery and radiation, prostate cancer is second only to lung cancer in male cancer deaths in the United States. Hormone therapy in the form of medical or surgical castration remains the mainstay of systemic treatment in prostate cancer.
β¦ LIBER β¦
958 THE IDENTIFICATION AND CHARACTERIZATION OF ANDROGEN-INDEPENDENT CELLS PRIOR TO HORMONAL MANIPULATION IN PROSTATE CANCER
β Scribed by Terada, Naoki; Shiraishi, Takumi; Zeng, Yu; Aw-Yong, Koh-Meng; Mooney, Steven; Luo, Jun; Kulkarni, Prakash; Getzenberg, Robert
- Book ID
- 118484707
- Publisher
- Lippincott Williams and Wilkins
- Year
- 2012
- Tongue
- English
- Weight
- 101 KB
- Volume
- 187
- Category
- Article
- ISSN
- 0022-5347
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Androgen receptor: A key molecule in the
β
Mary-Ellen Taplin; Steven P. Balk
π
Article
π
2004
π
John Wiley and Sons
π
English
β 91 KB
π 2 views
Mechanisms of resistance and adaptation
β
Dong I. Lee; Carlota Sumbilla; Myounghee Lee; Chidambaram Natesavelalar; Michael
π
Article
π
2007
π
Elsevier Science
π
English
β 552 KB
Regulation of genes involved in cell cyl
β
Petra Haag; Iris E Eder; Jasmin Bektic; Georg Bartsch; Helmut Klocker
π
Article
π
2003
π
Elsevier Science
π
English
β 88 KB
ANDROGEN-DEPENDENT REGULATION OF PROTEIN
β
T. Kobayashi; T. Inoue; N. Terada; Y. Shimizu; T. Yamasaki; T. Kamoto; O. Ogawa;
π
Article
π
2008
π
Elsevier Science
π
English
β 71 KB
Identification of genes targeted by the
Identification of genes targeted by the androgen and PKA signaling pathways in prostate cancer cells
β
Wang, G; Jones, S J M; Marra, M A; Sadar, M D
π
Article
π
2006
π
Nature Publishing Group
π
English
β 612 KB
Cyr61 downmodulation potentiates the ant
β
Monica Marra; Daniele Santini; Giuseppina Meo; Bruno Vincenzi; Silvia Zappavigna
π
Article
π
2009
π
John Wiley and Sons
π
French
β 477 KB
## Abstract We have analyzed the gene modulation induced by zoledronic acid (ZOL) in androgenβresistant prostate cancer PC3 cells with cDNA microarray platform to identify new molecular targets of ZOL in prostate cancer. The gene coding for cysteineβrich, angiogenic inducer, 61 (CYR61) resulted hig